AUGMENTIN 1gm In Skin And Soft Tissue Infection

• Status: Completed
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acid; Clavulanic Acids

Criteria

Inclusion Criteria:

• having diagnosed uncomplicated soft tissue infection (e.g furuncle, cellulitis)

• has given freely documented consent.

Exclusion Criteria:

• antibiotics

• have renal or hepatic insufficiency

• systemic toxicity

• pregnancy

• lactation

• hypersensitivity to penicillin or Beta-lactam antibiotics